🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Experimental Treatment Gaining Popularity Online

The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to contact these accounts privately for supplier links, while also obtaining promotional offers.

Active Commerce on Social Networks

Separately, a robust trade exists on Telegram, where communities with thousands of members share “before and after” photos, administration instructions and claims of next-day British shipping. Sellers market the substance there before directing buyers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Professionals Voice Worries

However, physicians and pharmacists have warned that the sale of what is still an unapproved drug in the United Kingdom is worrisome and could lead to users injecting products of unknown origin.

Several professionals said the demand for the experimental drug could be connected to the rising price of approved weight loss products such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still breach medicines, advertising, and consumer laws, potentially leading to penalties, legal action or imprisonment.

Service Response and Material Elimination

Based on the social media company, the platform has taken down problematic material and banned related keywords and query recommendations. The organization said it was dedicated to maintaining the platform secure and investing in strengthening enforcement strategies.

Online Trading Activities

Research also discovered groups with up to nine thousand participants marketing retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up channels with numerous of members, filled with photos of slimming results, positive reviews and step-by-step guides for preparing or administering at residence.

Within moments of entering one group, a seller posted contact information, where most purchases occur. The vendor provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about body mass, medical conditions or past usage.

Item Details and Costs

Inside these communities, messages display dark colored parcels with Royal Mail labels, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with purified liquid, or ready-to-use pens typically priced at £160 for 20 milligrams. When asked how much time a pen should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for Telegram said it actively monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting substances they cannot confirm. Even if the research behind retatrutide is sound, these digital products may not include what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to current price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, individuals are using social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.

Her staff has already encountered patients injured by personal administration from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they said, adding that any item “falsely representing itself as a company experimental substance not yet approved … may expose users to potentially significant medical dangers”.